Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S LOUIS

Showing results (171-180 of 293) with videos related to

Pageof 30
Sort By:
Arthritis Care & Research|March 26, 2016
Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid ArthritisHawre Jalal, James R O'Dell, S Louis Bridges, et al.
Arthritis and Rheumatism|May 21, 2013
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trialJames R O'Dell, Jeffrey R Curtis, Ted R Mikuls, et al.
Arthritis Care & Research|April 24, 2014
Socioeconomic disparities in the health of african americans with rheumatoid arthritis from the southeastern United StatesAntoine R Baldassari, Rebecca J Cleveland, Beth L Jonas, et al.
International Journal of Rheumatology|July 31, 2012
Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Karina I Halilova, Elizabeth E Brown, Sarah L Morgan, et al.
Journal of Psychosocial Oncology|June 15, 2017
Psychological distress and lifestyle disruption in low-risk prostate cancer patients: Comparison between active surveillance and radical prostatectomyAndrew G Matthew, Orit Raz, Kristen L Currie, et al.
The Prostate|August 6, 2010
Expression and function of ATIP/MTUS1 in human prostate cancer cell linesSimon N S Louis, Laurie Chow, Linda Rezmann, et al.
Biochemical Pharmacology|July 28, 2004
Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43))Linda A Rezmann-Vitti, Simon N S Louis, Tracy L Nero, et al.
The Prostate|February 22, 2008
Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell linesL Chow, L Rezmann, K Imamura, et al.
Journal of Medicinal Chemistry|June 9, 2006
Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptorLinda A Rezmann-Vitti, Tracy L Nero, Graham P Jackman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2014
HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residuesRichard J Reynolds, Altan F Ahmed, Maria I Danila, et al.
Pageof 30

Showing results (171-180 of 293) with videos related to

Sort By:
Pageof 30
Arthritis Care & Research|March 26, 2016
Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid ArthritisHawre Jalal, James R O'Dell, S Louis Bridges, et al.
Arthritis and Rheumatism|May 21, 2013
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trialJames R O'Dell, Jeffrey R Curtis, Ted R Mikuls, et al.
Arthritis Care & Research|April 24, 2014
Socioeconomic disparities in the health of african americans with rheumatoid arthritis from the southeastern United StatesAntoine R Baldassari, Rebecca J Cleveland, Beth L Jonas, et al.
International Journal of Rheumatology|July 31, 2012
Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Karina I Halilova, Elizabeth E Brown, Sarah L Morgan, et al.
Journal of Psychosocial Oncology|June 15, 2017
Psychological distress and lifestyle disruption in low-risk prostate cancer patients: Comparison between active surveillance and radical prostatectomyAndrew G Matthew, Orit Raz, Kristen L Currie, et al.
The Prostate|August 6, 2010
Expression and function of ATIP/MTUS1 in human prostate cancer cell linesSimon N S Louis, Laurie Chow, Linda Rezmann, et al.
Biochemical Pharmacology|July 28, 2004
Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43))Linda A Rezmann-Vitti, Simon N S Louis, Tracy L Nero, et al.
The Prostate|February 22, 2008
Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell linesL Chow, L Rezmann, K Imamura, et al.
Journal of Medicinal Chemistry|June 9, 2006
Role of Tyr(356(7.43)) and Ser(190(4.57)) in antagonist binding in the rat beta1-adrenergic receptorLinda A Rezmann-Vitti, Tracy L Nero, Graham P Jackman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2014
HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residuesRichard J Reynolds, Altan F Ahmed, Maria I Danila, et al.
Pageof 30